Retatrutide (pronounced reh-TAT-tru-tide) is a synthetic peptide-based therapy that activates three key hormone receptors involved in metabolism: GLP-1 receptor (Glucagon-Like Peptide-1) GIP receptor (Glucose-Dependent Insulinotropic Polypeptide) Glucagon receptor This makes Retatrutide a triple agonist a unique advancement over medications like semaglutide (Wegovy/Ozempic) and tirzepatide (Mounjaro/Zepbound) , which activate only one or two of these receptors
An additional quantity of vehicle was added to the beaker, rinsed, and transferred to the volumetric flask
Think of GLP-1s as the brakes that stop you from overeating, and NAD+ as the gas that gives you the energy to live your life
Discussing this with biotech/pharma sponsors and building some dose escalation buffer into a protocol to keep the participant in the study and manage these AEs (when possible) can be a good strategy to keep participants in the trial & improve their experience
Tatucu-Babet OA, Forsyth A, Udy A, Radcliffe J, Benheim D, Calkin C, et al
(1985): Stereospecific effects of acetylcarnitine on the spontaneous activity of brainstem neurones and their response to acetylcholine and serotonin
